April 22, 2021
A batch of new medicines hit the Japan market on April 21 upon their NHI price listing, including AstraZeneca’s chronic lymphocytic leukemia (CLL) treatment Calquence (acalabrutinib), the first blood cancer drug that the company has rolled out in the country...read more